Document Security Systems DSS
Last Post: 07/31/2023 10:00:26 AM
Board Marks: 10
Posts Today: 0
Board Views Today: 140
03/20/2019 10:09:51 PM
03/20/2019 1:05:07 PM
03/20/2019 1:02:30 PM
03/20/2019 12:51:31 PM
03/20/2019 12:33:13 PM
03/19/2019 12:52:35 PM
03/05/2019 4:13:49 PM
03/05/2019 2:21:28 PM
11/07/2018 7:17:37 PM
03/25/2018 11:12:36 AM
11/09/2014 9:03:05 AM
10/20/2012 2:01:35 PM
Recent Articles
- Steve Lehman Joins LiveOne as Vice Chairman to Drive Growth
- Aether Holdings Welcomes New Leadership to Accelerate Growth
- Viemed Healthcare Initiates Strategic Share Buyback Initiative
- MoneyHero Group Unveils Expanded Digital Asset Services
- BitMine Immersion Technologies Expands Bitcoin Treasury Holdings
- PDS Biotech to Lead Discussion on HPV Treatment Innovations
- Humacyte's V007 Trial Results Shed Light on AV Access Innovations
- Mizuho Americas Triumphs in Global Markets Awards Recognition
- Engaging Investor Conferences Planned by LifeMD This June
- Westwood Holdings Group's Monthly Income Distribution Insights
- Nutanix Webinar on Cloud Native Solutions to Enhance Operations
- Aventis Energy's Ambitious Exploration Strategies for Uranium
- GrowGeneration's Strategic Move with Viagrow Acquisition
- Exciting Developments at Hard Rock Hotel & Casino Ottawa
- ModeX Therapeutics Forms an Advisory Board of Immunology Experts
- Innovative Connectivity Solutions by Trading Technologies Thrive
- Hyperscale Data Predicts Stronger Revenue with Gresham Exit
- Unleashing AI Power: AuditPro.ai's Revolutionary Platform
- NV5 Secures $5 Million Contract for Innovative Substation Design
- First Orion Introduces Advanced SENTRY Spoof Protection for Calls
- STMicroelectronics Shares Buyback Program Gains Momentum
- Innovative Partnership Launches Maris Investments in Tech Sector
- Dacora Motors Redefines Luxury with Innovative Electric Vehicle
- AirJoule Technologies to be Included in Prestigious Russell Index
- TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment
- Neowise Biotechnology Collaborates with BeOne on Cell Therapies
- Shanghai Electric Unveils Innovative Solutions for Carbon Neutrality
- Hub International Enhances Financial Solutions with Veripax Deal
- Aethlon Medical Showcases Innovative Research on Long COVID
- Ballers Pioneers Social Sports Concept with Ambitious Growth Plans
- Dilon Technologies Secures $9 Million for Innovation Growth
- SOB100: Pioneering Exosome Therapy for Cancer Research
- Empowering Future Generations: South University Foundation Launch
- Psilera Teams with Hesperos to Enhance FTD Drug Development
- Aspen Neuroscience Unveils Innovative Stem Cell Therapy for Parkinson's
- Greg Campbell to Lead Newton Golf’s Participation in TableTalk
- Exploring BCC Mining's Innovative Approach to Cryptocurrency
- Navigating the Evolving Landscape of Alternative Investments
- Dynavax Encourages Support for Director Nominees Amid Changes
- Investors Urged to Join Fortrea Holdings Lawsuit Against Executives
- Nimanode Presale Surges: Key Factors Behind $NMA Growth
- Exploring Bitcoin Solaris: An Exciting New Crypto Opportunity
- BioRestorative's Promising Data Presentation at ISSCR 2025
- Plug Power Expands Global Reach with Major 2 GW Partnership
- PolyPid's Phase 3 Trial Success: Impactful Findings from SHIELD II
- Alarum Technologies Boosts Revenue Projections for 2025
- Palvella Therapeutics Secures FDA Grant for QTORIN™ Trials
- LeddarTech Expands Financial Options and Welcomes Back Employees
- Nutriband Strengthens Patent Protection with New U.S. Patent
- Ranchero Gold Welcomes New Independent Director to Board
